Showing results (591-600 of 13,798) with videos related to

Sort By:
Pageof 1,380
Annals of Surgical Oncology|September 25, 2009
Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestationNobuyuki Wada, Kiminori Sugino, Takashi Mimura, et al.
Annals of Surgical Oncology|July 29, 2009
S-100B concentrations predict disease-free survival in stage III melanoma patientsS Kruijff, E Bastiaannet, A C Muller Kobold, et al.
Annals of Surgical Oncology|July 29, 2009
Clinical and prognostic significance of urinary trypsin inhibitor in patients with hepatocellular carcinoma after hepatectomyIsao Kikuchi, Hiroshi Uchinami, Hiroshi Nanjo, et al.
Annals of Surgical Oncology|August 28, 2009
Prognostic significance of a positive nonsentinel lymph node in cutaneous melanomaAmir A Ghaferi, Sandra L Wong, Timothy M Johnson, et al.
Annals of Surgical Oncology|September 19, 2009
Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resectionKaitlyn J Kelly, Joyce Wong, Rebecca Gladdy, et al.
Annals of Surgical Oncology|July 8, 2009
Disparities in gastric cancer outcomes among Asian ethnicities in the USAJoseph Kim, Brian Mailey, Maheswari Senthil, et al.
Annals of Surgical Oncology|July 18, 2009
Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapyThomas A d'Amato, Brian L Pettiford, Mathew J Schuchert, et al.
Annals of Surgical Oncology|September 4, 2009
Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation?Jerome Byam, Nathaniel P Reuter, Charles E Woodall, et al.
Annals of Surgical Oncology|September 4, 2009
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosisRoberto Santambrogio, Enrico Opocher, Massimo Zuin, et al.
Annals of Surgical Oncology|August 13, 2009
IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesisDawei Li, Dongwang Yan, Huamei Tang, et al.
Pageof 1,380